CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Heavy buying witnessed in this penny stock under Rs 5; Board likely to announce bonus shares and stock split!
DSIJ Intelligence

Heavy buying witnessed in this penny stock under Rs 5; Board likely to announce bonus shares and stock split!

The stock has a 52-week high of Rs 3.68 and a 52-week low of Rs 1.52.

On Wednesday, one of the Top Gainers on BSE, shares of Earum Pharmaceuticals jumped 10 per cent upper circuit to Rs 1.72 per share from its previous closing of Rs 1.57. The stock has a 52-week high of Rs 3.68 and a 52-week low of Rs 1.52.

The sudden rise in the stock price is due to the company announcing that a meeting of the Board of Directors will be held on Friday, July 14, 2023 to discuss and consider inter alia:

  1. The proposal for Buyback of Equity Shares of the Company.
  2. The proposal to recommend the declaration of the Final dividend for the F.Y. 2022-23.
  3. The proposal to Issue of bonus Equity Shares to the existing equity Shareholders of the Company.
  4. The proposal for the sub-division of equity shares of the Company.
  5. To finalize the date, day, time and venue of the Annual General Meeting of shareholders for the F.Y. 2022-23.

Want more insightful stories along with recommendations?
Get a 3-month subscription to experience the power of our flagship DSIJ Magazine (online edition) for just Rs 800/-  Click here to subscribe now

Earum Pharmaceuticals Limited produces and distributes pharmaceutical products. The company offers tablets, capsules, ointments, creams, gels, powders, and syrup. Earum Pharmaceuticals markets its products globally.

Earum Pharmaceuticals has a market cap of Rs 42.50 crore. The company reported positive numbers in its both Quarterly Results and annual results.

Investors should keep an eye on this micro-cap stock.

Previous Article 52-week high alert: Only buyers in this multibagger small-cap stock with a stellar Rs 18,824.43 crore order book!
Next Article Shares of automobile company rose by 4 per cent after new launch!
Print
17148 Rate this article:
3.8
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR